14Jul 2023
Feasibility of 5‐fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3

Feasibility of 5‐fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3

A pilot study evaluated topical 5-fluorouracil (5-FU) and imiquimod for treating cervical intraepithelial neoplasia (CIN) 2/3. Participants applied 5% 5-FU and imiquimod alternately. Most participants (84.61%) applied 50% or more of the treatment doses. Grade 1 adverse events were reported by all participants, with 46.15% experiencing grade 2 adverse events. None reported grade 3/4 adverse events. Histologic regression and negative high-risk human papillomavirus (hrHPV) tests were observed in most participants. The study suggests topical therapy could be a feasible and potentially effective alternative to surgical treatment for CIN 2/3.

  • #gynaecology - ivf

Like

Save

Share